Searched for
SUN PHARMA DIVIDEND FY2026
India's current account deficit to remain 1.5-1.7% of GDP in FY27 but RBI measures may turn BoP surplus: SBI ReportIndia's current account deficit is projected for FY27. However, Reserve Bank of India measures are anticipated to improve the country's ext...- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Infosys dividend alert! Last date to buy IT giant's shares to secure Rs 25/sh payoutInfosys has set June 10 as the record date to determine shareholder eligibility for its final dividend of Rs 25 per share. Since shares mus...
- State Bank of India hands over Rs 8,813 cr dividend cheque to government for FY26SBI presented a dividend cheque of Rs 8,813 crore for the financial year 2025-26 to Union Finance Minister Nirmala Sitharaman. This payout ...
- SBI pays Rs 8,813 crore dividend to government for FY26, FM Nirmala Sitharaman receives chequeThe State Bank of India (SBI) presented a dividend cheque of Rs 8,813 crore to the government for the financial year ending March 31, 2026....
- Central Bank of India targets over Rs 3,500 crore bad-loan recovery in FY27Central Bank of India plans significant recovery from bad loans exceeding Rs 3,500 crore in FY27. The bank will also introduce wealth manag...
- Reliance Industries dividend alert! Last date to buy shares of Mukesh Ambani-led company for Rs 6 final dividendReliance Industries has set June 5 as the record date for its final dividend of Rs 6 per share for FY26, making June 4 the last day to buy ...
- Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...
- Did Anand Rathi Wealth shares really crash 50% in one day? Here's how the 1:1 bonus math worksAnand Rathi Wealth shares appeared to tumble nearly 50% after turning ex-bonus for its 1:1 bonus issue. The decline was purely due to a pri...
- Aegis Logistics shares rally 4% as Q4 profit rises 45% YoY; Board recommends dividendAegis Logistics shares rose sharply after the company reported a 45% year-on-year rise in Q4 FY26 consolidated net profit to Rs 413 crore, ...
- Bonus issues, dividends and more: Reliance Industries, Trent among 20 stocks turning ex-date this weekReliance Industries, Trent, and 18 other stocks are set to turn ex-date this week for corporate actions including dividends and bonus issue...
- Asian Paints' board announces Rs 23/share dividend, sets June 23 as record dateAsian Paints Dividend: The company has fixed June 23, 2026, as the record date to determine shareholders eligible to receive the final divi...
- Lincoln Pharmaceuticals posts Rs 11.63 crore profit for Q4Lincoln Pharmaceuticals announced a slight profit rise for the fourth quarter ending March 31, 2026. Full fiscal year 2025-26 saw over 6 pe...
- Dividend alert! Last date to buy Bajaj Auto, GSK Pharma and 10 other stocks for solid payouts. Details hereTwelve companies are set to go ex-dividend on Friday, offering shareholders payouts totaling over Rs 250. Bajaj Auto leads with a Rs 150 pe...
- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
- Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...
- Eicher Motors Q4 Results: Cons profit grows 12% YoY to Rs 1,520 crore, revenue jumps 16%Eicher Motors, the maker of Royal Enfield, posted a 12% rise in net profit for the March quarter of FY26. The company's revenue also saw a ...
- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...
- Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments BankBenchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to c...
Load More
